Afficher la notice abrégée

dc.creatorRapani A., Nikiforaki D., Karagkouni D., Sfakianoudis K., Tsioulou P., Grigoriadis S., Maziotis E., Pantou A., Voutsina A., Pantou A., Koutsilieris M., Hatzigeorgiou A., Pantos K., Simopoulou M.en
dc.date.accessioned2023-01-31T09:51:10Z
dc.date.available2023-01-31T09:51:10Z
dc.date.issued2021
dc.identifier10.3389/fcell.2020.590106
dc.identifier.issn2296634X
dc.identifier.urihttp://hdl.handle.net/11615/78456
dc.description.abstractOvarian insufficiency is identified as a perplexing entity in the long list of pathologies impairing fertility dynamics. The three distinct classifications of ovarian insufficiency are poor ovarian response, premature ovarian insufficiency/failure, and advanced maternal age, sharing the common denominator of deteriorated ovarian reserve. Despite efforts to define clear lines among the three, the vast heterogeneity and overlap of clinical characteristics renders their diagnosis and management challenging. Lack of a consensus has prompted an empirically based management coupled by uncertainty from the clinicians’ perspective. Profiling of patients in the era of precision medicine seems to be the way forward, while the necessity for a novel approach is underlined. Implicating miRNAs in the quest for patient profiling is promising in light of their fundamental role in cellular and gene expression regulation. To this end, the current study sets out to explore and compare the three pathophysiologies—from a molecular point of view—in order to enable profiling of patients in the context of in vitro fertilization treatment and enrich the data required to practice individualized medicine. Following a systematic investigation of literature, data referring to miRNAs were collected for each patient category based on five included studies. miRNA–target pairs were retrieved from the DIANA-TarBase repository and microT-CDS. Gene and miRNA annotations were derived from Ensembl and miRbase. A subsequent gene-set enrichment analysis of miRNA targets was performed for each category separately. A literature review on the most crucial of the detected pathways was performed to reveal their relevance to fertility deterioration. Results supported that all three pathophysiologies share a common ground regarding the affected pathways, naturally attributed to the common denominator of ovarian insufficiency. As evidenced, miRNAs could be employed to explore the fine lines and diverse nature of pathophysiology since they constitute invaluable biomarkers. Interestingly, it is the differentiation through miRNAs and not through the molecular affected pathways that corresponds to the three distinctive categories. Alarming discrepancies among publications were revealed, pertaining to employment of empirical and arbitrary criteria in categorizing the patients. Following bioinformatic analysis, the final step of the current study consisted of a critical analysis of the molecular data sourced, providing a clear and unique insight into the physiological mechanisms involved. It is our intention to contribute to mapping future research dedicated to ovarian insufficiency and to help researchers navigate the overwhelming information published in molecular studies. © Copyright © 2021 Rapani, Nikiforaki, Karagkouni, Sfakianoudis, Tsioulou, Grigoriadis, Maziotis, Pantou, Voutsina, Pantou, Koutsilieris, Hatzigeorgiou, Pantos and Simopoulou.en
dc.language.isoenen
dc.sourceFrontiers in Cell and Developmental Biologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85100048479&doi=10.3389%2ffcell.2020.590106&partnerID=40&md5=5ffdef58f6427b5e4b9891e63b7c6a17
dc.subjectcomplementary DNAen
dc.subjectcyclic AMPen
dc.subjectcyclin dependent kinase 1en
dc.subjectdouble stranded DNAen
dc.subjectepidermal growth factoren
dc.subjectepidermal growth factor receptor 2en
dc.subjectestradiolen
dc.subjectglycanen
dc.subjectglycoproteinen
dc.subjectgonadorelinen
dc.subjectgonadotropinen
dc.subjectgrowth hormoneen
dc.subjecthydroxymethylglutaryl coenzyme A reductaseen
dc.subjectJanus kinaseen
dc.subjectmammalian target of rapamycinen
dc.subjectmammalian target of rapamycin complex 2en
dc.subjectmicroRN 885 5pen
dc.subjectmicroRNAen
dc.subjectmicroRNA 106b5pen
dc.subjectmicroRNA 1180 3pen
dc.subjectmicroRNA 1197en
dc.subjectmicroRNA 122 5pen
dc.subjectmicroRNA 1226 3pen
dc.subjectmicroRNA 1247 5pen
dc.subjectmicroRNA 127 5pen
dc.subjectmicroRNA 129 5pen
dc.subjectmicroRNA 1306 5pen
dc.subjectmicroRNA 133a 3pen
dc.subjectmicroRNA 133ben
dc.subjectmicroRNA 135b 5pen
dc.subjectmicroRNA 139 3pen
dc.subjectmicroRNA 1468 5pen
dc.subjectmicroRNA 1469en
dc.subjectmicroRNA 146aen
dc.subjectmicroRNA 146a 5pen
dc.subjectmicroRNA 15a 5pen
dc.subjectmicroRNA 181a 2 3pen
dc.subjectmicroRNA 181a 3pen
dc.subjectmicroRNA 184en
dc.subjectmicroRNA 193a 5pen
dc.subjectmicroRNA 194 5pen
dc.subjectmicroRNA 199a 3pen
dc.subjectmicroRNA 199a 5pen
dc.subjectmicroRNA 199b 3pen
dc.subjectmicroRNA 20b 5pen
dc.subjectmicroRNA 214 3pen
dc.subjectmicroRNA 214 5pen
dc.subjectmicroRNA 23a 3pen
dc.subjectmicroRNA 23b 5pen
dc.subjectmicroRNA 26b 5pen
dc.subjectmicroRNA 27 5pen
dc.subjectmicroRNA 27a 3pen
dc.subjectmicroRNA 296 5pen
dc.subjectmicroRNA 3120 3pen
dc.subjectmicroRNA 3120 5pen
dc.subjectmicroRNA 3141en
dc.subjectmicroRNA 32 3pen
dc.subjectmicroRNA 326en
dc.subjectmicroRNA 328 3pen
dc.subjectmicroRNA 337 5pen
dc.subjectmicroRNA 34 3pen
dc.subjectmicroRNA 342 3pen
dc.subjectmicroRNA 343 3pen
dc.subjectmicroRNA 3591 3pen
dc.subjectmicroRNA 3614 5pen
dc.subjectmicroRNA 363en
dc.subjectmicroRNA 3664 3pen
dc.subjectmicroRNA 374b 5pen
dc.subjectmicroRNA 374c 3pen
dc.subjectmicroRNA 376a 5pen
dc.subjectmicroRNA 376c 5pen
dc.subjectmicroRNA 378a 3pen
dc.subjectmicroRNA 378den
dc.subjectmicroRNA 380 5pen
dc.subjectmicroRNA 3960en
dc.subjectmicroRNA 4279en
dc.subjectmicroRNA 4286en
dc.subjectmicroRNA 431 3pen
dc.subjectmicroRNA 4422en
dc.subjectmicroRNA 4433a 3pen
dc.subjectmicroRNA 4433b 3pen
dc.subjectmicroRNA 4448en
dc.subjectmicroRNA 450a 2 3pen
dc.subjectmicroRNA 450b 3pen
dc.subjectmicroRNA 452 5pen
dc.subjectmicroRNA 4700 5pen
dc.subjectmicroRNA 4751en
dc.subjectmicroRNA 483 3pen
dc.subjectmicroRNA 483 5pen
dc.subjectmicroRNA 493 5pen
dc.subjectmicroRNA 497 3pen
dc.subjectmicroRNA 500a 3pen
dc.subjectmicroRNA 501 3pen
dc.subjectmicroRNA 506 3pen
dc.subjectmicroRNA 508 3pen
dc.subjectmicroRNA 508 5pen
dc.subjectmicroRNA 509 3pen
dc.subjectmicroRNA 511 5pen
dc.subjectmicroRNA 513a 5pen
dc.subjectmicroRNA 513b 5pen
dc.subjectmicroRNA 513c 5pen
dc.subjectmicroRNA 532 3pen
dc.subjectmicroRNA 542 3pen
dc.subjectmicroRNA 586en
dc.subjectmicroRNA 6087en
dc.subjectmicroRNA 636en
dc.subjectmicroRNA 6510 3pen
dc.subjectmicroRNA 654 5pen
dc.subjectmicroRNA 655 3pen
dc.subjectmicroRNA 6722 3pen
dc.subjectmicroRNA 6795 5pen
dc.subjectmicroRNA 8079en
dc.subjectmicroRNA 885 5pen
dc.subjectmitochondrial DNAen
dc.subjectmitogen activated protein kinaseen
dc.subjectMuellerian inhibiting factoren
dc.subjectneurotrophinen
dc.subjectoxytocinen
dc.subjectparathyroid hormoneen
dc.subjectphosphatidylinositol 3 kinaseen
dc.subjectprotein BADen
dc.subjectprotein bcl 2en
dc.subjectprotein kinase Ben
dc.subjectprotein p53en
dc.subjectprotein tyrosine kinaseen
dc.subjectproteoheparan sulfateen
dc.subjectsmall untranslated RNAen
dc.subjectSTAT proteinen
dc.subjecttranscription factor FOXOen
dc.subjecttransforming growth factor betaen
dc.subjecttumor necrosis factor receptor associated factor 6en
dc.subjectunclassified drugen
dc.subjectvasculotropin receptoren
dc.subjectWnt proteinen
dc.subjectactin filamenten
dc.subjectadulten
dc.subjectAMPK signalingen
dc.subjectapoptosisen
dc.subjectArticleen
dc.subjectbioinformaticsen
dc.subjectcell agingen
dc.subjectcell functionen
dc.subjectcell interactionen
dc.subjectcontrolled studyen
dc.subjectfemaleen
dc.subjectfemale fertilityen
dc.subjectgap junctionen
dc.subjectgene expressionen
dc.subjectglucose metabolismen
dc.subjecthippo signalingen
dc.subjecthumanen
dc.subjectin vitro fertilizationen
dc.subjectinfertility therapyen
dc.subjectJAK-STAT signalingen
dc.subjectmaternal ageen
dc.subjectmeiosisen
dc.subjectmicroarray analysisen
dc.subjectmitophagyen
dc.subjectmolecular biologyen
dc.subjectmTOR signalingen
dc.subjectoocyteen
dc.subjectoocyte retrievalen
dc.subjectovary follicle developmenten
dc.subjectovary insufficiencyen
dc.subjectpathophysiologyen
dc.subjectPi3K/Akt signalingen
dc.subjectpoor ovarian responseen
dc.subjectpregnancy complicationen
dc.subjectpremature ovarian failureen
dc.subjectprotein fingerprintingen
dc.subjectRNA extractionen
dc.subjectRNA sequencingen
dc.subjectsignal transductionen
dc.subjectsystematic reviewen
dc.subjectWnt signalingen
dc.subjectFrontiers Media S.A.en
dc.titleReporting on the Role of miRNAs and Affected Pathways on the Molecular Backbone of Ovarian Insufficiency: A Systematic Review and Critical Analysis Mapping of Future Researchen
dc.typejournalArticleen


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée